Pharmaceuticals
Design, Synthesis, and Evaluation of Novel Adenine-Based Hydrazones as Potential Anticancer Agents: Cytotoxicity Against A549 and MRC-5 Cell Lines with In Silico Insights
Door Menteşe E, Çalışkan N, Emirik M en 1 anderen.
Inhoud in het Engels
Abstract
Background/Objectives: Lung cancer remains a leading cause of global cancer-related mortality, necessitating the development of new therapeutic candidates. In this study, we aimed to design, synthesize, and biologically evaluate novel adenine-based hydrazone derivatives as potential anticancer candidates.